Updating results

318 results for template

Sort: Relevance | Date

Recognising and preventing delirium

diagnosis and management - NICE guideline, including assessment and care plan templates in tools and resources Delirium in adults - NICE...

Published May 2019 Last updated May 2019

Infliximab for the treatment of adults with psoriasis (TA134)

Evidence-based recommendations on infliximab (Remicade) for treating psoriasis in adults

Technology appraisal guidance Published January 2008

Adalimumab for the treatment of adults with psoriasis (TA146)

Evidence-based recommendations on adalimumab (Humira) for the treatment of adults with plaque psoriasis

Technology appraisal guidance Published June 2008

Laparoscopic surgery for colorectal cancer (TA105)

Evidence-based recommendations on laparoscopic surgery for colorectal (bowel) cancer

Technology appraisal guidance Published August 2006

Epilepsy in adults (QS26)

This quality standard covers diagnosing, treating and managing epilepsy and seizures in adults (aged 18 and older). It describes high-quality care in priority areas for improvement.

Quality standard Published February 2013

Biosimilar medicines (KTT15)

for adoption has been developed with accompanying guidance, resources and template documents, including the Cancer Vanguard biosimilars...

Key therapeutic topic Published February 2016 Last updated February 2018

Dementia resource for carers and care providers - quality statement 2: choice and control in decisions

'The person', 'The family', and 'The staff and manager', also includes a template for an action plan – to be completed after the...

Published February 2017 Last updated 

Atopic eczema in under 12s: diagnosis and management (CG57)

This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity.

Clinical guideline Published December 2007

Drug misuse in over 16s: psychosocial interventions (CG51)

This guideline covers using psychosocial interventions to treat adults and young people over 16 who have a problem with or are dependent on opioids, stimulants or cannabis. It aims to reduce illicit drug use and improve people’s physical and mental health, relationships and employment.

Clinical guideline Published July 2007

Prolaris gene expression assay for assessing long-term risk of prostate cancer progression (MIB65)

Advice on the use of the Prolaris gene expression assay for assessing the risk of prostate cancer progression to aid local decision-making

Medtech innovation briefing Published May 2016

Dementia resource for carers and care providers

People with dementia, with the involvement of their carers, have choice and control in decisions affecting their care and support.

Published February 2017 Last updated February 2017

Breast cancer (QS12)

This quality standard covers the care of people with breast cancer after they have been referred to a specialist team. It includes the management of early (ductal carcinoma in situ and invasive), locally advanced and advanced breast cancer; recurrent breast cancer; and familial breast cancer. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2011 Last updated June 2016

Contraception (QS129)

This quality standard covers contraception for women, including emergency contraception. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2016

Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome (TA139)

Evidence-based recommendations on continuous positive airway pressure (CPAP) for the treatment of obstructive sleep apnoea/hypopnoea syndrome

Technology appraisal guidance Published March 2008

SeQuent Please balloon catheter for in-stent coronary restenosis (MTG1)

Evidence-based recommendations on SeQuent Please balloon catheter for in-stent coronary restenosis

Medical technologies guidance Published December 2010

CardioQ-ODM oesophageal doppler monitor (MTG3)

Evidence-based recommendations on the CardioQ-ODM oesophageal doppler monitor for people having major or high-risk surgery

Medical technologies guidance Published March 2011

Epilepsy in children and young people (QS27)

This quality standard covers diagnosing, treating and managing epilepsy and seizures in children and young people (under 18). It describes high-quality care in priority areas for improvement.

Quality standard Published February 2013

Transition between inpatient hospital settings and community or care home settings for adults with social care needs (QS136)

This quality standard covers admissions into, and discharge from, inpatient hospital settings for adults (aged 18 years and over) with social care needs. It describes high-quality care in priority areas for improvement. It does not cover inpatient mental health settings, which will be covered by a quality standard on transition between inpatient mental health settings and community or care home settings.

Quality standard Published December 2016

Medicines optimisation in chronic pain (KTT21)

Prescribing and Therapeutics Branch of NHS Scotland. These include an EMIS template for chronic pain review, audits and patient...

Key therapeutic topic Published January 2017 Last updated March 2019

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma (TA137)

Evidence-based recommendations on rituximab (MabThera) for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma

Technology appraisal guidance Published February 2008

Sunitinib for the treatment of gastrointestinal stromal tumours (TA179)

Evidence-based recommendations on sunitinib (Sutent) for treating gastrointestinal stromal tumours (cancer of stomach/digestive system)

Technology appraisal guidance Published September 2009

Pemetrexed for the maintenance treatment of non-small-cell lung cancer (TA190)

Evidence-based recommendations on pemetrexed disodium (Alimta) for the maintenance treatment of non-small-cell lung cancer (NSCLC)

Technology appraisal guidance Published June 2010 Last updated August 2017

Evidence summaries: new medicines – Integrated process statement (PMG11)

Evidence summaries: new medicines – Integrated process statement

Published May 2013 Last updated March 2017 Last updated March 2017

Mental health problems in people with learning disabilities: prevention, assessment and management (NG54)

This guideline covers preventing, assessing and managing mental health problems in people with learning disabilities in all settings (including health, social care, education, and forensic and criminal justice). It aims to improve assessment and support for mental health conditions, and help people with learning disabilities and their families and carers to be involved in their care.

NICE guideline Published September 2016

Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups (QS167)

This quality standard covers promoting health and preventing premature mortality among black, Asian and other minority ethnic groups. It is relevant to all age groups and all settings.

Quality standard Published May 2018

Preventing unintentional injury in under 15s (QS107)

This quality standard covers preventing unintentional injury in children and young people (under 15). It includes local coordination of prevention strategies, and advice and assessment to help prevent accidents in the home. It describes high-quality care in priority areas for improvement.

Quality standard Published January 2016

Gastro-oesophageal reflux in children and young people (QS112)

This quality standard covers managing symptoms of reflux (regurgitation or bringing up feeds) in babies, children and young people (under 18). It also covers diagnosing and managing gastro-oesophageal reflux disease (also called GORD), which is more severe reflux and heartburn. It describes high-quality care in priority areas for improvement.

Quality standard Published January 2016

Motor neurone disease (QS126)

This quality standard covers assessing and managing motor neurone disease, including care, support and planning after diagnosis. It describes high-quality care in priority areas for improvement.

Quality standard Published July 2016

Evidence summaries: unlicensed and off-label medicines – Interim process statement (PMG2)

Evidence summaries: unlicensed and off-label medicines – Interim process statement

Published August 2012 Last updated August 2012

Bivalirudin for the treatment of ST-segment-elevation myocardial infarction (TA230)

Evidence-based recommendations on bivalirudin (Angiox) for treating ST-segment-elevation myocardial infarction (STEMI)

Technology appraisal guidance Published July 2011

Febuxostat for the management of hyperuricaemia in people with gout (TA164)

Evidence-based recommendations on febuxostat (Adenuric) for the management of hyperuricaemia in people with gout

Technology appraisal guidance Published December 2008

Care and support of people growing older with learning disabilities

Everything NICE has said on the care and support of people growing older with learning disabilities

NICE Pathway Published April 2018 Last updated July 2019

Obesity prevention (CG43)

This guideline covers preventing children, young people and adults becoming overweight or obese. It outlines how the NHS, local authorities, early years’ settings, schools and workplaces can increase physical activity levels and make dietary improvements among their target populations.

Clinical guideline Published December 2006 Last updated March 2015

Bortezomib monotherapy for relapsed multiple myeloma (TA129)

Evidence-based recommendations on bortezomib monotherapy (Velcade) for treating relapsed multiple myeloma (bone marrow cancer)

Technology appraisal guidance Published October 2007

Alitretinoin for the treatment of severe chronic hand eczema (TA177)

Evidence-based recommendatrions on alitretinoin (Toctino) for treating severe chronic hand eczema in adults

Technology appraisal guidance Published August 2009

Omalizumab for previously treated chronic spontaneous urticaria (TA339)

Evidence-based recommendations on omalizumab (Xolair) for treating previously treated severe chronic spontaneous urticaria (hives)

Technology appraisal guidance Published June 2015

Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)

Evidence summaries: unlicensed and off-label medicines – Integrated process statement

Published May 2013 Last updated March 2017 Last updated March 2017

Obesity in adults: prevention and lifestyle weight management programmes (QS111)

This quality standard covers preventing adults (aged 18 and over) from becoming overweight or obese. It includes strategies to increase physical activity and promote a healthy diet in the local population. It also covers lifestyle weight management programmes for adults who are overweight or obese. It describes high-quality care in priority areas for improvement.

Quality standard Published January 2016

Home care for older people (QS123)

This quality standard covers care and support for older people living in their own homes (known as home care or domiciliary care). It covers people aged over 65 using home care services, and may also cover some people under 65 with complex needs. It describes high-quality care in priority areas for improvement.

Quality standard Published June 2016

Medicines optimisation (QS120)

This quality standard covers the safe and effective use of medicines. It covers people of all ages who are taking medicines, including those who are not getting the full benefit from their medicines. It describes high-quality care in priority areas for improvement.

Quality standard Published March 2016

Guide to the methods of technology appraisal 2013 (PMG9)

Guide to the methods of technology appraisal 2013

Published April 2013 Last updated April 2013

Patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures (IPG196)

Evidence-based recommendations on patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures

Interventional procedures guidance Published November 2006

Falls in older people (QS86)

This quality standard covers prevention of falls and assessment after a fall in older people (aged 65 and over) who are living in the community or staying in hospital. It describes high-quality care in priority areas for improvement.

Quality standard Published March 2015 Last updated January 2017

Pembrolizumab for advanced melanoma not previously treated with ipilimumab (TA366)

Evidence-based recommendations on pembrolizumab (Keytruda) for treating advanced melanoma in adults not previously treated with ipilimumab

Technology appraisal guidance Published November 2015 Last updated September 2017

Pemetrexed for the first-line treatment of non-small-cell lung cancer (TA181)

Evidence-based recommendations on pemetrexed disodium (Alimta) for the first-line treatment of non-small-cell lung cancer (NSCLC)

Technology appraisal guidance Published September 2009

Docetaxel for the treatment of hormone-refractory metastatic prostate cancer (TA101)

Evidence-based recommendations on docetaxel (Taxotere) for the treatment of hormone-refractory metastatic (advanced) prostate cancer

Technology appraisal guidance Published June 2006

Sexually transmitted infections and under-18 conceptions: prevention (PH3)

This guideline covers one-to-one interventions to prevent sexually transmitted infections (STIs) and under-18 conceptions. The aim is to reduce the transmission of chlamydia and other STIs, including HIV, and reduce the rate of pregnancies among women aged under 18.

Public health guideline Published February 2007

Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer (TA100)

Evidence-based recommendations on capecitabine (Xeloda) and oxaliplatin (Eloxatin) for adjuvant treatment of stage III (Dukes' C) colon (bowel) cancer

Technology appraisal guidance Published April 2006